223 related articles for article (PubMed ID: 1428537)
1. Application of arylsulphonyl side-chain protected arginines in solid-phase peptide synthesis based on 9-fluorenylmethoxycarbonyl amino protecting strategy.
Fischer PM; Retson KV; Tyler MI; Howden ME
Int J Pept Protein Res; 1992 Jul; 40(1):19-24. PubMed ID: 1428537
[TBL] [Abstract][Full Text] [Related]
2. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
Fields CG; VanDrisse VL; Fields GB
Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
[TBL] [Abstract][Full Text] [Related]
3. New mild acid-labile protecting groups for the guanidino function of N alpha-fluorenylmethoxycarbonyl-L-arginine in solid-phase peptide synthesis: 10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl, 2-methoxy-10,11-dihydoro-5H-dibenzo[a,d]cyclohepten-5-yl and 5H-dibenzo[a,d]cyclohepten-5-yl groups.
Noda M; Kiffe M
J Pept Res; 1997 Nov; 50(5):329-35. PubMed ID: 9401916
[TBL] [Abstract][Full Text] [Related]
4. Liquid-phase peptide synthesis on polyethylene glycol (PEG) supports using strategies based on the 9-fluorenylmethoxycarbonyl amino protecting group: application of PEGylated peptides in biochemical assays.
Fischer PM; Zheleva DI
J Pept Sci; 2002 Sep; 8(9):529-42. PubMed ID: 12371706
[TBL] [Abstract][Full Text] [Related]
5. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis.
King DS; Fields CG; Fields GB
Int J Pept Protein Res; 1990 Sep; 36(3):255-66. PubMed ID: 2279849
[TBL] [Abstract][Full Text] [Related]
6. Revisiting NO
Alhassan M; Kumar A; Lopez J; Albericio F; de la Torre BG
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586051
[TBL] [Abstract][Full Text] [Related]
7. Sulfonation of arginine residues as side reaction in Fmoc-peptide synthesis.
Beck-Sickinger AG; Schnorrenberg G; Metzger J; Jung G
Int J Pept Protein Res; 1991 Jul; 38(1):25-31. PubMed ID: 1938103
[TBL] [Abstract][Full Text] [Related]
8. Orthogonal protecting groups for N(alpha)-amino and C-terminal carboxyl functions in solid-phase peptide synthesis.
Albericio F
Biopolymers; 2000; 55(2):123-39. PubMed ID: 11074410
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of peptides containing phosphoserine using phosphate tert.-butyl protecting group.
Lacombe JM; Andriamanampisoa F; Pavia AA
Int J Pept Protein Res; 1990 Sep; 36(3):275-80. PubMed ID: 2279850
[TBL] [Abstract][Full Text] [Related]
10. p-Nitrobenzyl side-chain protection for solid-phase synthesis.
Hocker MD; Caldwell CG; Macsata RW; Lyttle MH
Pept Res; 1995; 8(6):310-15. PubMed ID: 8838413
[TBL] [Abstract][Full Text] [Related]
11. Sequence-dependent modification of Trp by the Pmc protecting group of Arg during TFA deprotection.
Stierandová A; Sepetov NF; Nikiforovich GV; Lebl M
Int J Pept Protein Res; 1994 Jan; 43(1):31-8. PubMed ID: 8138350
[TBL] [Abstract][Full Text] [Related]
12. Sustainable Peptide Synthesis Enabled by a Transient Protecting Group.
Knauer S; Koch N; Uth C; Meusinger R; Avrutina O; Kolmar H
Angew Chem Int Ed Engl; 2020 Jul; 59(31):12984-12990. PubMed ID: 32324944
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and application of acid labile anchor groups for the synthesis of peptide amides by Fmoc-solid-phase peptide synthesis.
Breipohl G; Knolle J; Stüber W
Int J Pept Protein Res; 1989 Oct; 34(4):262-7. PubMed ID: 2599764
[TBL] [Abstract][Full Text] [Related]
14. [Side reactions in peptide synthesis. V. O-sulfonation of serine and threonine during removal of pmc- and mtr-protecting groups from arginine residues in fmoc-solid phase synthesis].
Jaeger E; Remmer HA; Jung G; Metzger J; Oberthür W; Rücknagel KP; Schäfer W; Sonnenbichler J; Zetl I
Biol Chem Hoppe Seyler; 1993 May; 374(5):349-62. PubMed ID: 8338636
[TBL] [Abstract][Full Text] [Related]
15. Immunological effects of an arginine side chain contaminating synthetically prepared peptides.
Schlagel LJ; Bors L; Mitchell GW; King JL; Cao L; Kirk M; Whitaker JN
Mol Immunol; 1997 Feb; 34(2):185-94. PubMed ID: 9188851
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Sulfotyrosine-Containing Peptides by Incorporating Fluorosulfated Tyrosine Using an Fmoc-Based Solid-Phase Strategy.
Chen W; Dong J; Li S; Liu Y; Wang Y; Yoon L; Wu P; Sharpless KB; Kelly JW
Angew Chem Int Ed Engl; 2016 Jan; 55(5):1835-8. PubMed ID: 26696445
[TBL] [Abstract][Full Text] [Related]
17. Incomplete TFA deprotection of N-terminal trityl-asparagine residue in fmoc solid-phase peptide chemistry.
Friede M; Denery S; Neimark J; Kieffer S; Gausepohl H; Briand JP
Pept Res; 1992; 5(3):145-7. PubMed ID: 1421802
[TBL] [Abstract][Full Text] [Related]
18. Microwave-assisted cleavage of Alloc and Allyl Ester protecting groups in solid phase peptide synthesis.
Wilson KR; Sedberry S; Pescatore R; Vinton D; Love B; Ballard S; Wham BC; Hutchison SK; Williamson EJ
J Pept Sci; 2016 Oct; 22(10):622-627. PubMed ID: 27501347
[TBL] [Abstract][Full Text] [Related]
19. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
Ruczyński J; Lewandowska B; Mucha P; Rekowski P
J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
[TBL] [Abstract][Full Text] [Related]
20. Handles for Fmoc solid-phase synthesis of protected peptides.
Góngora-Benítez M; Tulla-Puche J; Albericio F
ACS Comb Sci; 2013 May; 15(5):217-28. PubMed ID: 23573835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
